Book Value Per Share: The amount of equity available to shareholders expressed on a per common share basis. Calculated as: Total Shareholders Equity / Common Shares Outstanding
REGENXBIO Inc. (RGNX) had Book Value Per Share of $2.02 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$170.44M |
|
$-193.88M |
|
$20.30M |
|
$150.14M |
|
$331.64M |
|
$-161.20M |
|
$-32.68M |
|
$-193.88M |
|
$-193.88M |
|
$-193.88M |
|
$-193.88M |
|
$-193.88M |
|
$-193.88M |
|
$-161.20M |
|
$-145.58M |
|
51.57M |
|
51.57M |
|
$-3.76 |
|
$-3.76 |
|
| Balance Sheet Financials | |
$281.28M |
|
$104.86M |
|
$171.75M |
|
$453.03M |
|
$118.09M |
|
-- |
|
$232.20M |
|
$350.30M |
|
$102.73M |
|
$102.73M |
|
$102.73M |
|
50.89M |
|
| Cash Flow Statement Financials | |
$-123.96M |
|
$-15.87M |
|
$116.77M |
|
$59.56M |
|
$36.50M |
|
$-23.06M |
|
$34.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.38 |
|
-- |
|
-- |
|
-- |
|
-- |
|
88.09% |
|
-94.58% |
|
-94.58% |
|
-85.42% |
|
-113.75% |
|
-113.75% |
|
$-126.38M |
|
-- |
|
-- |
|
-- |
|
0.38 |
|
-- |
|
6.46 |
|
56.49 |
|
-188.72% |
|
-188.72% |
|
-42.80% |
|
-188.72% |
|
|
Book Value Per Share |
$2.02 |
$-2.45 |
|
$-2.40 |
|